Cargando…
Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan
BACKGROUND: Group B Streptococcus (GBS) is a leading pathogen causing life-threatening bacterial infections in neonates (early- or late-onset) and infants, and is associated with preterm and stillbirth. Japan introduced national guidelines to reduce early-onset neonatal GBS disease, with universal p...
Autores principales: | Sorano, Sumire, Procter, Simon R, Seale, Anna C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333677/ https://www.ncbi.nlm.nih.gov/pubmed/37441365 http://dx.doi.org/10.1016/j.jvacx.2023.100332 |
Ejemplares similares
-
Vaccine hesitancy in Japan: Is the country well prepared for Tokyo 2020?
por: Shimizu, Kazuki, et al.
Publicado: (2020) -
Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness
por: Procter, Simon R., et al.
Publicado: (2023) -
Why is it so difficult to access emergency contraceptive pills in Japan?
por: Sorano, Sumire, et al.
Publicado: (2021) -
Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions
por: Seale, Anna C., et al.
Publicado: (2019) -
Vaccination with the immunoglobulin M-degrading enzyme of Streptococcus suis, Ide(Ssuis), leads to protection against a highly virulent serotype 9 strain
por: Rieckmann, Karoline, et al.
Publicado: (2019)